Cellular Biomedicine Group, Inc. Credit Agreements
4 Contracts & Agreements
- China Merchants Bank approval of a credit line of up to RMB 30 million to SBM Shanghai (Filed With SEC on August 12, 2020)
- Nanjing Bank approval of a credit line of up to RMB 30 million to CBMG Wuxi (Filed With SEC on August 12, 2020)
- Nanjing Bank approval of a credit line of up to RMB 30 million to CBMG Wuxi (Filed With SEC on May 6, 2020)
- Credit Agreement, dated as of January 19, 2019, by and between Shanghai Cellular Biopharmaceutical Group Ltd. and China Merchants Bank Co., Ltd., Shanghai Branch (Filed With SEC on January 25, 2019)
